MEDIROM Healthcare Technologies Inc.
MRM News Today: Stay Updated with the Latest MEDIROM Healthcare Technologies Inc. News in Real Time
Find MRM news now at Meyka AI. Stay informed with the latest MEDIROM Healthcare Technologies Inc. stocks updates, including price news, market analysis, and expert insights.
RPI-UN.TO bounces 1.1% in pre-market as oversold signals emerge
RPI-UN.TO stock rises 1.1% in pre-market trading on April 24, 2026. Richards Packaging rebounds from oversold conditions with strong dividend yield.
0638.HK Fibocom Wireless Earnings: Q1 2026 Results
Fibocom Wireless (0638.HK) reported Q1 2026 earnings with $1.93B revenue and $0.0124 EPS on April 23, 2026.
DMN Stock Plunges 86% in One Year as Damon Inc. Faces Challenges
DMN stock trades at $0.0017 with 2.2B volume. Damon Inc. faces steep 86% decline over 12 months amid operational headwinds.
MTRAF: BMO Capital Maintains Outperform Rating April 2026
BMO Capital maintains Outperform rating on Metro Inc. (MTRAF) with price target lowered to C$105 from C$110 on April 23, 2026.
3NIO.AS Stock Plunges 16.36% on EURONEXT, April 24 2026
3NIO.AS stock crashes 16.36% to €20.98 on EURONEXT. Leverage Shares 3x Long NIO ETC faces sharp decline amid market volatility.
DeepSeek Makes a Comeback with a New Model Following Viral Success
DeepSeek is back in the spotlight as it launches a new artificial intelligence model after its earlier viral success shocked the global tech market. The Chinese AI startup had gained rapid attention for delivering strong performance at lower cost, raising questions about global AI competition and pricing models. Now, with its latest release, DeepSeek is…
ROG.SW Stock Gains 0.5% on April 24, 2026 – Roche Holding AG
ROG.SW stock price at CHF322.3, up 0.5% today on SIX exchange. Roche Holding AG trades with 778,976 volume.
RLF.SW Stock Bounces 0.87% on April 24 as Biotech Finds Support
Relief Therapeutics (RLF.SW) rises 0.87% to CHF 2.885 on SIX. Biotech stock shows oversold bounce signals amid clinical trials.
1513.HK Livzon Pharmaceutical Misses Q1 2026 Earnings Targets
Livzon Pharmaceutical (1513.HK) missed EPS and revenue estimates in April. EPS down 9.66%, revenue down 9.50%. Stock at HK$28.26.